Business
Smith+Nephew to host Meet the Management event
Smith+Nephew to host Meet the Management event.
About this update from Smith & Nephew Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 8641P\n Smith & Nephew Plc\n 22 October 2021\n \n \n \n \n Smith+Nephew to host Meet the Management event\n \n \n 22 October 2021\n \n \n \n \n \n Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces that it will be holding a virtual Meet the Management event for institutional investors and analysts from 12:30pm GMT (7:30am EST) on 16 December 2021.\n \n \n \n \n \n The event will consist of a formal presentation, followed by break-out group meetings with members of the senior leadership team including the Chief Executive Officer, Chief Financial Officer, and Presidents of the global franchises.\n \n \n \n \n \n Institutional investors or analysts wishing to take part should register on the Smith+Nephew corporate website: \n \n www.smith-nephew.com/meetthemanagement\n \n . \n \n \n \n \n \n Additionally, the formal presentation will be streamed live with a replay available after the event.\n \n \n \n \n \n \n \n \n Enquiries\n \n \n \n \n \n Investors/ Analysts\n \n \n Andrew Swift +44 (0) 1923 477433\n \n \n Smith+Nephew \n \n \n \n \n \n Media\n \n \n Charles Reynolds +44 (0) 1923 477314\n \n \n Smith+Nephew\n \n \n \n \n \n \n \n \n About Smith+Nephew\n \n \n Smith+Nephew is a portfolio medical technology business that exists to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 18,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Advanced Wound Management and Sports Medicine & ENT. Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $4.6 billion in 2020. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.\n \n \n \n \n \n For more information about Smith+Nephew, please visit \n \n www.smith-nephew.com\n \n and follow us on \n \n Twitter\n \n , \n ...